SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013594-14-000723
Filing Date
2014-12-23
Accepted
2014-12-22 18:27:46
Documents
5

Document Format Files

Seq Description Document Type Size
1 DECEMBER 22, 2014 echo13da-122214.htm SC 13D/A 196317
2 LETTER AGREEMENT echoex991-122214.htm EX-99.1 71683
3 SECURITIES PURCHASE AGREEMENT echoex992-122214.htm EX-99.2 237601
4 CERTIFICATE OF DESIGNATION echoex993-122214.htm EX-99.3 76385
5 FORM OF WARRANT echoex994-122214.htm EX-99.4 53494
  Complete submission text file 0001013594-14-000723.txt   637367
Mailing Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103
Business Address 8 PENN CENTER 1628 JFK BLVD, SUITE 300 PHILADELPHIA PA 19103 215-717-4100
Echo Therapeutics, Inc. (Subject) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52931 | Film No.: 141304197
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 212-581-0500
Platinum Partners Value Arbitrage Fund, LP (Filed by) CIK: 0001299265 (see all company filings)

IRS No.: 141861954 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A